SCHEMBL5571569

SCHEMBL5571569

CC(=O)N1CCC(COC(N)=O)(c2ccccc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 2/20 0.57
KCNA3 P22001 1/20 0.52
MEN1 O00255 1/20 0.49
RAB9A P51151 1/20 0.49
KMT2A Q03164 1/20 0.49
CYP2D6 P10635 3/20 0.47
USP2 O75604 2/20 0.47
CHRM5 P08912 3/20 0.47
CHRM1 P11229 3/20 0.47
CHRM3 P20309 3/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 2/20 0.46
CYP2C19 P33261 2/20 0.46
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
OPRM1 P35372 1/20 0.45
HSD11B1 P28845 4/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12601480 0.87 TACR1 (0.58) TACR1KCNA3MEN1RAB9AKMT2A
Hydrochloric Acid SCHEMBL3595461 0.81 MAOA (0.56) TACR1KCNA3MEN1RAB9AKMT2A
SCHEMBL13059781 0.81 KCNA3 (0.54) TACR1KCNA3MEN1RAB9AKMT2A
SCHEMBL28611554 0.80 NPFFR1 (0.58) TACR1CYP2D6USP2CHRM3ALDH1A1
SCHEMBL5568767 0.78 TACR1 (0.56) TACR1OPRM1HSD11B1
SCHEMBL5571567 0.76 P2RX7 (0.56) TACR1KCNA3MEN1KMT2ACYP2D6
SCHEMBL7971201 0.76 ALDH1A1 (0.47) TACR1CHRM5CHRM1CHRM3ALDH1A1
SCHEMBL5380076 0.75 HSD11B1 (0.48) TACR1KCNA3MEN1KMT2ACYP2D6
SCHEMBL7975314 0.75 HSD11B1 (0.55) MEN1RAB9AKMT2ACYP2D6USP2
SCHEMBL3593944 0.75 TACR1 (0.48) TACR1KCNA3MEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781623-A1 COMPOUNDS AND COMPOSITIONS USEFUL AS CATHEPSIN S INHIBITORS Novartis AG (CH) 2007-05-09 EP disclosed
WO-2006018284-A1 COMPOUNDS AND COMPOSITIONS USEFUL AS CATHEPSIN S INHIBITORS NOVARTIS AG (CH) 2006-02-23 WO disclosed